135 related articles for article (PubMed ID: 9039817)
1. Oral pilocarpine improves radiotherapy-induced dry eyes.
Kumar S; Tyler AB; Phillips S; Burnet NG
Clin Oncol (R Coll Radiol); 1997; 9(1):62-3. PubMed ID: 9039817
[TBL] [Abstract][Full Text] [Related]
2. [Pilocarpine--new use for an old drug].
Tishler M
Harefuah; 1998 Aug; 135(3-4):150-2. PubMed ID: 9885666
[No Abstract] [Full Text] [Related]
3. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.
Davies AN; Shorthose K
Cochrane Database Syst Rev; 2007 Jul; (3):CD003782. PubMed ID: 17636736
[TBL] [Abstract][Full Text] [Related]
4. Re: Researchers make slow headway in managing dry mouth.
LeVeque F
J Natl Cancer Inst; 1997 Dec; 89(24):1894-5. PubMed ID: 9414180
[No Abstract] [Full Text] [Related]
5. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.
Vivino FB; Al-Hashimi I; Khan Z; LeVeque FG; Salisbury PL; Tran-Johnson TK; Muscoplat CC; Trivedi M; Goldlust B; Gallagher SC
Arch Intern Med; 1999 Jan; 159(2):174-81. PubMed ID: 9927101
[TBL] [Abstract][Full Text] [Related]
6. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
7. Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?
Cooper RA; Cowan RA; Owens SE; Jeans SP; Roberts JK; Hillel PG; Slevin NJ; Allan E; Gupta NK; Collins CD
Eur J Nucl Med; 1999 Mar; 26(3):220-5. PubMed ID: 10079311
[TBL] [Abstract][Full Text] [Related]
8. Oral pilocarpine for xerostomia.
Med Lett Drugs Ther; 1994 Aug; 36(929):76. PubMed ID: 8047049
[No Abstract] [Full Text] [Related]
9. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
de Castro G; Federico MH
Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
[TBL] [Abstract][Full Text] [Related]
10. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
Horiot JC; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun RJ; Ardiet JM; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J
Radiother Oncol; 2000 Jun; 55(3):233-9. PubMed ID: 11041775
[TBL] [Abstract][Full Text] [Related]
11. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia.
Jacobs CD; van der Pas M
Oncology (Williston Park); 1996 Mar; 10(3 Suppl):16-20. PubMed ID: 8723429
[TBL] [Abstract][Full Text] [Related]
12. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy.
Garg AK; Malo M
J Am Dent Assoc; 1997 Aug; 128(8):1128-33. PubMed ID: 9260423
[TBL] [Abstract][Full Text] [Related]
13. Evolving radiation therapy techniques for scalp angiosarcoma.
Ko S
Surg Oncol; 2018 Dec; 27(4):A1-A2. PubMed ID: 30292558
[No Abstract] [Full Text] [Related]
14. Pilocarpine in the prevention of postirradiation xerostomia.
Lajtman Z; Krajina Z; Krpan D; Vincelj J; Borcić V; Popović-Kovacić J
Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111
[TBL] [Abstract][Full Text] [Related]
15. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
16. Combined surgical and X-ray treatment for angiosarcoma of the scalp: report of a case with a favourable outcome.
Brand CU; Yawalkar N; von Briel C; Hunziker T
Br J Dermatol; 1996 Apr; 134(4):763-5. PubMed ID: 8733388
[TBL] [Abstract][Full Text] [Related]
17. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
Nieuw Amerongen AV; Veerman EC
Support Care Cancer; 2003 Apr; 11(4):226-31. PubMed ID: 12673460
[TBL] [Abstract][Full Text] [Related]
18. Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies.
Johnstone PA; Peng YP; May BC; Inouye WS; Niemtzow RC
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):353-7. PubMed ID: 11380221
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of radioprotective effect of pilocarpine ingestion on salivary glands.
Pimentel MJ; Filho MM; Araújo M; Gomes DQ; DA Costa LJ
Anticancer Res; 2014 Apr; 34(4):1993-9. PubMed ID: 24692737
[TBL] [Abstract][Full Text] [Related]
20. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
Valdez IH; Wolff A; Atkinson JC; Macynski AA; Fox PC
Cancer; 1993 Mar; 71(5):1848-51. PubMed ID: 8448748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
